SCHEMBL6632491

SCHEMBL6632491

COc1ccc(-c2c(C(C)(C)C)n[nH]c2N)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
CYP2A6 P11509 2/20 0.39
PIK3CA P42336 2/20 0.39
PIK3CD O00329 1/20 0.39
PIP5K1C O60331 1/20 0.39
PIK3CB P42338 1/20 0.39
PI4KA P42356 1/20 0.39
PIK3CG P48736 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
CHEK1 O14757 1/20 0.38
FYN P06241 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.37
HSD17B1 P14061 2/20 0.37
HSD17B2 P37059 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6572637 0.81 HPGDS (0.41) PIK3CAPIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL4898151 0.81 KDM4E (0.51) MAPTKDM4E
SCHEMBL4412336 0.74 SMN1; SMN2 (0.42) PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL29875184 0.74 ATR (0.45) MKNK1MKNK2CHEK1FYNHSD17B1
SCHEMBL19926325 0.74 ATR (0.45) MKNK1MKNK2CHEK1FYNHSD17B1
SCHEMBL1012506 0.72 AKT2 (0.47) MKNK1MKNK2CHEK1L3MBTL1CYP1A2
SCHEMBL1854897 0.71 ADORA2B (0.44) MKNK1MKNK2CYP2A6PIK3CAPIK3CD
SCHEMBL4009647 0.71 MAPK1 (0.47) LOXL2MAPTKDM4E
SCHEMBL19459337 0.71 KIF11 (0.42) MKNK1MKNK2L3MBTL1KDM4E
Hydrochloric Acid SCHEMBL1858316 0.70 ADORA2B (0.43) MKNK1MKNK2CYP2A6PIK3CAPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480973-A1 1,4-DISUBSTITUTED BENZOFUSED CYCLOALKYL UREA COMPOUNDS USEFUL IN TREATING CYTOKINE MEDIATED DISEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2004-12-01 EP disclosed
WO-2003072569-A1 1,4-DISUBSTITUTED BENZOFUSED CYCLOALKYL UREA COMPOUNDS USEFUL IN TREATING CYTOKINE MEDIATED DISEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-09-04 WO disclosed